CIMBALI
Wednesday 25 December 2024
  • La Cimbali

PlantX receives bullish research valuation from Capital Y Management

Must read

  • Dalla Corte
TME - Cialdy Evo
Demuslab

VANCOUVER, BC, Canada – PlantX Life Inc. today announced that Capital Y Management, a New York-based hedge fund, has issued an independent research report on PlantX referring to PlantX as “a market leader with a disruptive business in an emerging industry with long term tailwinds”.

Capital Y Management has established a 12-month price target of C$0.67 per common share, which would represent an enterprise value for PlantX of approximately C$68 million.

“The PlantX team is hard at work to make plant-based diets available to everyone, expanding our presence in this rapidly growing market,” said PlantX CEO, Lorne Rapkin. “We are encouraged that this independent report has recognized that we are well-positioned. While we are not commenting on the specific projections, we are focused on achieving success similar to Capital Y’s outlook.”

The full report published in July 2022 and financial model can be viewed and downloaded from the PlantX website under Investors or by clicking here: https://investor.plantx.com/news/capital-y-report/

Any opinions, estimates or forecasts regarding the performance of PlantX and its management made by Capital Y Management are theirs alone and do not represent the opinions, estimates or forecasts of PlantX or its management. PlantX does not by this announcement or otherwise, imply that the Company endorses, analyzes or approves of such information, conclusions, or recommendations.

CIMBALI

Latest article

  • Franke Mytico
Demus Art of decaffeination